SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-266816
Filing Date
2022-10-21
Accepted
2022-10-21 17:06:03
Documents
13
Period of Report
2022-10-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d306821d8k.htm   iXBRL 8-K 29284
2 EX-99.1 d306821dex991.htm EX-99.1 13863
  Complete submission text file 0001193125-22-266816.txt   175815

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrn-20221020.xsd EX-101.SCH 2868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20221020_lab.xml EX-101.LAB 18692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20221020_pre.xml EX-101.PRE 11695
7 EXTRACTED XBRL INSTANCE DOCUMENT d306821d8k_htm.xml XML 3883
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 221324336
SIC: 2834 Pharmaceutical Preparations